194 related articles for article (PubMed ID: 17336444)
1. The effects of camptothecin on RNA polymerase II transcription: roles of DNA topoisomerase I.
Capranico G; Ferri F; Fogli MV; Russo A; Lotito L; Baranello L
Biochimie; 2007 Apr; 89(4):482-9. PubMed ID: 17336444
[TBL] [Abstract][Full Text] [Related]
2. DNA topoisomerase i as a transcription protein and a lethal cellular toxin.
Lotito L; Ferri F; Russo A; Capranico G
Ital J Biochem; 2007 Jun; 56(2):122-9. PubMed ID: 17722653
[TBL] [Abstract][Full Text] [Related]
3. Early effects of topoisomerase I inhibition on RNA polymerase II along transcribed genes in human cells.
Khobta A; Ferri F; Lotito L; Montecucco A; Rossi R; Capranico G
J Mol Biol; 2006 Mar; 357(1):127-38. PubMed ID: 16427078
[TBL] [Abstract][Full Text] [Related]
4. Camptothecin inhibits hsp 70 heat-shock transcription and induces DNA strand breaks in hsp 70 genes in Drosophila.
Rowe TC; Couto E; Kroll DJ
NCI Monogr; 1987; (4):49-53. PubMed ID: 2819731
[TBL] [Abstract][Full Text] [Related]
5. Role of flexibility and long range communication on the function of human topoisomerase I.
Chillemi G; Fiorani P; Bruselles A; Castelli S; Campagna A; Sarra O; Tesauro C; Fiorentini M; Vassallo O; D'Annessa I; Santoleri S; Desideri A
Ital J Biochem; 2007 Jun; 56(2):110-4. PubMed ID: 17722651
[TBL] [Abstract][Full Text] [Related]
6. Topoisomerase I and II inhibitors control caspase-2 pre-messenger RNA splicing in human cells.
Solier S; Lansiaux A; Logette E; Wu J; Soret J; Tazi J; Bailly C; Desoche L; Solary E; Corcos L
Mol Cancer Res; 2004 Jan; 2(1):53-61. PubMed ID: 14757846
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of camptothecin resistance by human topoisomerase I mutations.
Chrencik JE; Staker BL; Burgin AB; Pourquier P; Pommier Y; Stewart L; Redinbo MR
J Mol Biol; 2004 Jun; 339(4):773-84. PubMed ID: 15165849
[TBL] [Abstract][Full Text] [Related]
8. Cotranscriptional coupling of splicing factor recruitment and precursor messenger RNA splicing in mammalian cells.
Listerman I; Sapra AK; Neugebauer KM
Nat Struct Mol Biol; 2006 Sep; 13(9):815-22. PubMed ID: 16921380
[TBL] [Abstract][Full Text] [Related]
9. Nucleosomes represent a physical barrier for cleavage activity of DNA topoisomerase I in vivo.
Di Felice F; Chiani F; Camilloni G
Biochem J; 2008 Feb; 409(3):651-6. PubMed ID: 17967163
[TBL] [Abstract][Full Text] [Related]
10. Conformational information in DNA: its role in the interaction with DNA topoisomerase I and nucleosomes.
Caserta M; Camilloni G; Venditti S; Venditti P; Di Mauro E
J Cell Biochem; 1994 May; 55(1):93-7. PubMed ID: 8083304
[TBL] [Abstract][Full Text] [Related]
11. Association of topoisomerase I with transcriptionally active loci in Drosophila.
Gilmour DS; Elgin SC
NCI Monogr; 1987; (4):17-21. PubMed ID: 2819725
[TBL] [Abstract][Full Text] [Related]
12. Camptothecin-stabilized topoisomerase I-DNA adducts cause premature termination of transcription.
Bendixen C; Thomsen B; Alsner J; Westergaard O
Biochemistry; 1990 Jun; 29(23):5613-9. PubMed ID: 1696837
[TBL] [Abstract][Full Text] [Related]
13. Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes.
Zhang H; Wang JC; Liu LF
Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1060-4. PubMed ID: 2829214
[TBL] [Abstract][Full Text] [Related]
14. Dissecting the transcriptional functions of human DNA topoisomerase I by selective inhibitors: implications for physiological and therapeutic modulation of enzyme activity.
Capranico G; Marinello J; Baranello L
Biochim Biophys Acta; 2010 Dec; 1806(2):240-50. PubMed ID: 20600630
[TBL] [Abstract][Full Text] [Related]
15. Camptothecin: current perspectives.
Thomas CJ; Rahier NJ; Hecht SM
Bioorg Med Chem; 2004 Apr; 12(7):1585-604. PubMed ID: 15028252
[TBL] [Abstract][Full Text] [Related]
16. Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity.
Habermeyer M; Fritz J; Barthelmes HU; Christensen MO; Larsen MK; Boege F; Marko D
Chem Res Toxicol; 2005 Sep; 18(9):1395-404. PubMed ID: 16167831
[TBL] [Abstract][Full Text] [Related]
17. A specific transcriptional response of yeast cells to camptothecin dependent on the Swi4 and Mbp1 factors.
Lotito L; Russo A; Bueno S; Chillemi G; Fogli MV; Capranico G
Eur J Pharmacol; 2009 Jan; 603(1-3):29-36. PubMed ID: 19094980
[TBL] [Abstract][Full Text] [Related]
18. Elongation by RNA polymerase II on chromatin templates requires topoisomerase activity.
Mondal N; Zhang Y; Jonsson Z; Dhar SK; Kannapiran M; Parvin JD
Nucleic Acids Res; 2003 Sep; 31(17):5016-24. PubMed ID: 12930951
[TBL] [Abstract][Full Text] [Related]
19. Topoisomerases of kinetoplastid parasites: why so fascinating?
Das BB; Sengupta T; Ganguly A; Majumder HK
Mol Microbiol; 2006 Nov; 62(4):917-27. PubMed ID: 17042788
[TBL] [Abstract][Full Text] [Related]
20. Quinolones as enhancers of camptothecin-induced cytotoxic and anti-topoisomerase I effects.
Reuveni D; Halperin D; Shalit I; Priel E; Fabian I
Biochem Pharmacol; 2008 Mar; 75(6):1272-81. PubMed ID: 18191106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
